Advertisement

Related Videos

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Deborah Collyar: What's In It for Patients?

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Advertisement

Advertisement




Jul
14
Today In Oncology
Breast Cancer: Tailoring Radiotherapy Based on Nodal Response to Primary Chemotherapy
Novel Gene Therapy–Radiotherapy Combination in Localized Prostate Cancer
Advanced Breast Cancer Novel CDK4/6 Inhibitor Plus an Aromatase Inhibitor
Emergency Hospital Admission Accounts for 40 of Ovarian Cancer Diagnoses in England
Perioperative Systemic Therapy vs Surgery Alone in Colorectal Peritoneal-Only Metastases
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo